There have been many new biological drugs approved by the FDA to treat psoriasis since 2003 as one example of an inflated drug price that most lower income people can’t get access to because Medicaid and Medicare won’t pay for them due to the skyrocketing prices. The new blood thinner “Eliquis” is paid for by Medicaid and Medicare at $200 a bottle. The COPD inhalers which are fairly new are also paid for by the government without hesitation in the area of $150 a pop.
Subscribe to the newsletter news
We hate SPAM and promise to keep your email address safe